PwC’s MoneyTree™ Life Sciences report brings you a quarterly publication based on US venture capital funding for the life sciences sector. Each issue contains the following sections: life sciences deals by quarter, stages, regional funding trends and a venture capital outlook. We also break down the life sciences sector into its subsegments, including biotech and medical device, to compare funding and investment trends by quarter.
“Deal volume is a key performance indicator to measure investor confidence. However, even with volume down, the life sciences space continues to garner the most dollars behind the software industry.”